busulfan has been researched along with Myelomonocytic Leukemia, Chronic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radujkovic, A | 1 |
| Hegenbart, U | 1 |
| Müller-Tidow, C | 1 |
| Herfarth, K | 1 |
| Dreger, P | 1 |
| Luft, T | 1 |
| Zhao, XL | 1 |
| Jiang, EL | 1 |
| Zhai, WH | 1 |
| Ma, QL | 1 |
| Pang, AM | 1 |
| Wei, JL | 1 |
| He, Y | 1 |
| Yang, DL | 1 |
| Feng, SZ | 1 |
| Han, MZ | 1 |
| Yoshimi, A | 1 |
| Mohamed, M | 1 |
| Bierings, M | 1 |
| Urban, C | 1 |
| Korthof, E | 1 |
| Zecca, M | 1 |
| Sykora, KW | 1 |
| Duffner, U | 1 |
| Trebo, M | 1 |
| Matthes-Martin, S | 1 |
| Sedlacek, P | 1 |
| Klingebiel, T | 1 |
| Lang, P | 1 |
| Führer, M | 1 |
| Claviez, A | 1 |
| Wössmann, W | 1 |
| Pession, A | 1 |
| Arvidson, J | 1 |
| O'Marcaigh, AS | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Starý, J | 1 |
| Hasle, H | 1 |
| Nöllke, P | 1 |
| Locatelli, F | 1 |
| Niemeyer, CM | 1 |
| Randi, ML | 1 |
| Fabris, F | 1 |
| Girolami, A | 1 |
| Kolb, HJ | 1 |
| Holler, E | 1 |
| Bender-Götze, C | 1 |
| Walther, U | 1 |
| Mittermüller, J | 1 |
| Clemm, C | 1 |
| Bauchinger, M | 1 |
| Gerhartz, HH | 1 |
| Brehm, G | 1 |
| Ledderose, G | 1 |
1 trial available for busulfan and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality | 2007 |
4 other studies available for busulfan and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience.
Topics: Adult; Aged; Antilymphocyte Serum; Busulfan; Calcineurin Inhibitors; Disease-Free Survival; Female; | 2020 |
[Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia].
Topics: Adult; Busulfan; Decitabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; | 2019 |
Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Busulfan; Female; Follow-Up Studies; Humans; | 1999 |
Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuria.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Bone Marrow; Bone Marrow Transplantation; Busulfan | 1989 |